San Francisco startup Structure Therapeutics is likewise working on an oral, after-each day GLP-1 drug named GSBR-1290—the drug surpassed Wall Road’s expectations in June each time a mid-stage study confirmed typical weight loss of close to six% and it designs to get started on anoth